As of 2025-08-06, the Fair Value of Ginkgo Bioworks Holdings Inc (DNA) is -35.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.28 USD, the upside of Ginkgo Bioworks Holdings Inc is -346.59%.
With the market price of 14.28 USD and our fair value calculation, Ginkgo Bioworks Holdings Inc (DNA) is not a good investment. Investing in DNA stocks now will result in a potential loss of 346.59%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -126.60 | -1,830.00 | -2,104.90 | -892.87 | -547.03 | -1,100.28 |
| YoY growth | -6.12% | -1,345.50% | -15.02% | 57.58% | 38.73% | -254.06% |
| Market Cap (mil) | 957.20 |
| P/E | |
| Forward P/E |
| EPS | -7.04 |
| Avg earnings growth rate | -254.06% |
| TTM earnings | -472.07 |